ATE78261T1 - Esterderivate vom antibiotikum l 17046. - Google Patents

Esterderivate vom antibiotikum l 17046.

Info

Publication number
ATE78261T1
ATE78261T1 AT85113810T AT85113810T ATE78261T1 AT E78261 T1 ATE78261 T1 AT E78261T1 AT 85113810 T AT85113810 T AT 85113810T AT 85113810 T AT85113810 T AT 85113810T AT E78261 T1 ATE78261 T1 AT E78261T1
Authority
AT
Austria
Prior art keywords
antibiotic
ester derivatives
directed
antimicrobial activity
positive bacteria
Prior art date
Application number
AT85113810T
Other languages
English (en)
Inventor
Adriano Malabarba
Ambrogio Magni
Paolo Strazzolini
Bruno Cavalleri
Aldo Trani
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of ATE78261T1 publication Critical patent/ATE78261T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Catalysts (AREA)
AT85113810T 1984-11-13 1985-10-30 Esterderivate vom antibiotikum l 17046. ATE78261T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848428619A GB8428619D0 (en) 1984-11-13 1984-11-13 Derivatives of antibiotic l 17046
EP85113810A EP0182157B1 (de) 1984-11-13 1985-10-30 Esterderivate vom Antibiotikum L 17046

Publications (1)

Publication Number Publication Date
ATE78261T1 true ATE78261T1 (de) 1992-08-15

Family

ID=10569641

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85113810T ATE78261T1 (de) 1984-11-13 1985-10-30 Esterderivate vom antibiotikum l 17046.

Country Status (13)

Country Link
US (1) US4661470A (de)
EP (1) EP0182157B1 (de)
JP (1) JPS61122300A (de)
KR (1) KR860004076A (de)
AT (1) ATE78261T1 (de)
CA (1) CA1250098A (de)
DE (1) DE3586344T2 (de)
DK (1) DK508885A (de)
ES (1) ES8704964A1 (de)
GB (1) GB8428619D0 (de)
HU (1) HU196228B (de)
IL (1) IL76996A0 (de)
ZA (1) ZA858449B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE873523L (en) * 1986-12-30 1988-06-30 Memorex Corp Glycosylated glycopeptides
US4882313A (en) * 1987-07-31 1989-11-21 Smithkline Beckman Corporation Carboxamide derivatives of glycopeptides
GB8808658D0 (en) * 1988-04-13 1988-05-18 Lepetit Spa Aglycons of a/16686 antibiotics
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
AR021964A1 (es) * 1998-12-23 2002-09-04 Theravance Inc Un compuesto glicopeptidico, composiciones farmaceuticas que los contienen y uso de dichos compuestos glicopeptidicos para la manufactura de un medicamento antibacteriano.
AU768204B2 (en) 1998-12-23 2003-12-04 Cumberland Pharmaceuticals Inc. Glycopeptide derivatives and pharmaceutical compositions containing the same
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
AU2003294262B2 (en) * 2002-11-18 2007-08-23 Vicuron Pharmaceuticals Inc. Methods of administering dalbavancin for treatment of bacterial infections
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64486A (en) * 1980-12-18 1985-01-31 Lilly Co Eli Antibiotic a-4696 factor g,its preparation and use as feed supplement for ruminant animals
FI73697C (fi) * 1982-06-08 1987-11-09 Lepetit Spa Foerfarande foer framstaellning av individuella faktorer 1, 2, 3, 4 och 5 av teikomysin a2.
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
GB8415092D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Ester derivatives

Also Published As

Publication number Publication date
IL76996A0 (en) 1986-04-29
EP0182157A2 (de) 1986-05-28
CA1250098A (en) 1989-02-14
ES548789A0 (es) 1987-04-16
HU196228B (en) 1988-10-28
GB8428619D0 (en) 1984-12-19
US4661470A (en) 1987-04-28
JPS61122300A (ja) 1986-06-10
ES8704964A1 (es) 1987-04-16
DK508885A (da) 1986-05-14
DE3586344T2 (de) 1993-03-11
ZA858449B (en) 1986-08-27
EP0182157B1 (de) 1992-07-15
DK508885D0 (da) 1985-11-05
KR860004076A (ko) 1986-06-16
EP0182157A3 (en) 1987-12-09
DE3586344D1 (de) 1992-08-20
HUT41053A (en) 1987-03-30

Similar Documents

Publication Publication Date Title
DE69214397D1 (de) 2-Substituierte Indane-2-Carboxyalkyl-Verbindungen mit Enkephalinase und ACE-Hemmwirkung
ES470436A1 (es) Un procedimiento para la preparacion de un acido carboxilicoalilico
JO1704B1 (en) New potent compounds
ATE78261T1 (de) Esterderivate vom antibiotikum l 17046.
ATE75743T1 (de) Hydrazinderivate und ihre verwendung.
ES2129397T3 (es) Derivados heteroaroilo de antibioticos beta-lactamas monociclicos.
ES8609366A1 (es) Un procedimiento para preparar un derivado de ester de des- glucoteicoplanina
ES466037A1 (es) Un procedimiento para preparar derivados de oleandomicina.
FR2369259A1 (fr) Derives de 3,3-dichloro-2-azetidinone ayant une activite anti-inflammatoire
ES2090530T3 (es) Produccion de peces mejorada.
FR2355848A1 (fr) 7-(a-(2,3-dihydro-2-oxobenzimidazol-1-yl-carbonylamino) arylacetamido) cephalosporines
GR75173B (de)
ES2079724T3 (es) Nuevos compuestos antibioticos y su produccion.
ES8107309A1 (es) Un procedimiento de produccion de derivados de 7 -metoxice- falosporina
ES454009A1 (es) Un procedimiento para la preparacion de nuevos esteres de derivados del acido clavulanico.
SU1319521A1 (ru) 5-(2,2,2-Трифтор-1-окси-1-трифторметилэтил)фурил-2-метилгидразонийбромид, проявляющий антимикробную и противовоспалительную активность
UA9123A1 (uk) 1-гідроксіетил-3,5-бісгідроксиметил-1,3,5-гексагідротріазиhоh-4 як аhтимікробhа добавка для боротьби з біологічhим пошкоджеhhям мастильhо-охолоджувальhих емульсій
SU1823451A1 (ru) 2,3а-Дигидрокси-3-(4-толуоил)-3а,4-дигидро-1Н-пирроло[2,1-с][1, 4]бензоксазин-1,4-дион, проявляющий противомикробную активность в отношении кокковых форм бактерий
SU1302661A1 (ru) 3-(3,5-Диметилпиразолил-1)-6-(2-карбэтокси-1-метилэтилиден-1)гидразинопиридазин, обладающий противовоспалительной и противомикробной активностью
SU1246566A1 (ru) Три- или тетразамещенные 4н-селенопираны, проявляющие антимикробную и антифаговую активность
ITMI950971A1 (it) Derivati aminotiazolici di cefalosporine aventi attivita' antibatterica
SU731725A1 (ru) Производные дифенилилхинолина, обладающие противомикробной активностью
SU1088319A1 (ru) 2-Ацетилгидразино-4-(3,4-диоксифенил)-тиазол, проявляющий антимикробную активность в отношении кишечной палочки и золотистого стафилококка
SU1607351A1 (ru) 3-БЕНЗОИЛ-1-ФЕНИЛ-1Н-ПИРАЗОЛО[3,4-b]ХИНОКСАЛИН, ПРОЯВЛЯЮЩИЙ ПРОТИВОСТАФИЛОКОККОВУЮ АКТИВНОСТЬ
SU915438A1 (ru) Метиловый эфир 2-фенил-2-этилдибутилсилоксиуксусной кислоты, проявляющий противовоспалительную активность

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee